|
|
| | 1H-Indole-2-propanoic acid, 3-[(1,1-diMethylethyl)thio]-1-[[4-(6-Methoxy-3-pyridinyl)phenyl]Methyl]-,-diMethyl-5-(2-pyridinylMethoxy)- Basic information |
| | 1H-Indole-2-propanoic acid, 3-[(1,1-diMethylethyl)thio]-1-[[4-(6-Methoxy-3-pyridinyl)phenyl]Methyl]-,-diMethyl-5-(2-pyridinylMethoxy)- Chemical Properties |
| Melting point | 206 °C | | Boiling point | 779.3±60.0 °C(Predicted) | | density | 1.18±0.1 g/cm3(Predicted) | | pka | 4.70±0.10(Predicted) |
| | 1H-Indole-2-propanoic acid, 3-[(1,1-diMethylethyl)thio]-1-[[4-(6-Methoxy-3-pyridinyl)phenyl]Methyl]-,-diMethyl-5-(2-pyridinylMethoxy)- Usage And Synthesis |
| Uses | AM103 (free acid) is a selective FLAP inhibitor that can block the first step of the LT pathway, which is 5-LO activation. AM103 (free acid) can inhibit the production of LTB4 and cysteinyl leukotrienes (CysLT). AM103 (free acid) has anti-inflammatory activity in a mouse model of chronic lung inflammation and can extend the survival time of mice injected with platelet-activating factor. AM103 (free acid) can be used for research on respiratory diseases such as asthma[1]. | | References | [1] Lorrain D S, et al. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2, 2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation[J]. Journal of Pharmacology and Experimental Therapeutics, 2009, 331(3): 1042-1050. |
| | 1H-Indole-2-propanoic acid, 3-[(1,1-diMethylethyl)thio]-1-[[4-(6-Methoxy-3-pyridinyl)phenyl]Methyl]-,-diMethyl-5-(2-pyridinylMethoxy)- Preparation Products And Raw materials |
|